Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001

Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001–2020

Published:2017-06-27 Issue:9 Volume:95 Page:629-638
ISSN:0042-9686
Container-title:Bulletin of the World Health Organization
language:
Short-container-title:Bull. World Health Organ.

Author:

Ozawa Sachiko¹,Clark Samantha²,Portnoy Allison³,Grewal Simrun⁴,Stack Meghan L⁵,Sinha Anushua⁶,Mirelman Andrew⁷,Franklin Heather⁶,Friberg Ingrid K⁸,Tam Yvonne²,Walker Neff²,Clark Andrew⁹,Ferrari Matthew¹⁰,Suraratdecha Chutima¹¹,Sweet Steven¹²,Goldie Sue J¹²,Garske Tini¹³,Li Michelle¹⁴,Hansen Peter M¹⁵,Johnson Hope L¹⁴,Walker Damian¹⁶

Affiliation:

1. Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, CB # 7574, Beard Hall 115H, Chapel Hill, North Carolina, 27599, United States of America (USA).

2. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.

3. Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, USA.

4. Department of Pharmacy, University of Washington, Seattle, USA.

5. Independent Consultant, Denver, USA.

6. Department of Preventive Medicine and Community Health, Rutgers New Jersey Medical School, Newark, USA.

7. Centre for Health Economics, University of York, York, England.

8. Department of Health Services, Norwegian Institute of Public Health, Oslo, Norway.

9. Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, England.

10. Center for Infectious Disease Dynamics, The Pennsylvania State University, University Park, USA.

11. Independent Consultant, Vienna, USA.

12. Center for Health Decision Science, Harvard TH Chan School of Public Health, Boston, USA.

13. MRC Centre for Outbreak Analysis and Modelling, Imperial College London, London, England.

14. Gavi, the Vaccine Alliance, Geneva, Switzerland.

15. The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.

16. Bill & Melinda Gates Foundation, Seattle, USA.

Publisher

WHO Press

Subject

Public Health, Environmental and Occupational Health

Reference41 articles.

1. Brenzel L, Wolfson L, Fox-Rushby JA, Miller MA, Halsey N. Chapter 20: Vaccine-preventable diseases. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., editors. Disease control priorities in developing countries. 2nd ed. Washington (DC): World Bank; 2006. pp. 389–411. Available from: http://www.ncbi.nlm.nih.gov/books/NBK11768/ [cited 2017 Jun 5].

2. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.;Ozawa;Vaccine,2012

3. Valuing vaccination.;Bärnighausen;Proc Natl Acad Sci USA,2014

4. Vaccines: from valuation to resource allocation.;Bloom;Vaccine,2015

5. Return on investment from childhood immunization in low- and middle-income countries, 2011-20.;Ozawa;Health Aff (Millwood),2016

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene-Editing and RNA Interference in Treating Hepatitis B: A Review;Viruses;2023-12-08

2. Public health impact and return on investment of the pediatric immunization program in Poland;Expert Review of Vaccines;2023-11-09

3. Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush: a quasi-experimental study and economic evaluation;2023-10-27

4. How to increase and maintain high immunization coverage: Vaccination Demand Resilience (VDR) framework;Vaccine;2023-10

5. Inequality of Opportunity and Early Childhood Development in Togo;2023-07-12